Cargando…
Inhibitors of Discoidin Domain Receptor (DDR) Kinases for Cancer and Inflammation
The discoidin domain receptor tyrosine kinases DDR1 and DDR2 are distinguished from other kinase enzymes by their extracellular domains, which interact with collagen rather than with peptidic growth factors, before initiating signaling via tyrosine phosphorylation. They share significant sequence an...
Autores principales: | Denny, William A., Flanagan, Jack U. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615839/ https://www.ncbi.nlm.nih.gov/pubmed/34827669 http://dx.doi.org/10.3390/biom11111671 |
Ejemplares similares
-
The tyrosine kinase inhibitor nilotinib targets the discoidin domain receptor DDR2 in calcific aortic valve stenosis
por: Carracedo, Miguel, et al.
Publicado: (2022) -
Discoidin Domain Receptor-1 (DDR1) is Involved in Angiolymphatic Invasion in Oral Cancer
por: Chen, Yu-Lian, et al.
Publicado: (2020) -
Identification of Receptor Tyrosine Kinase, Discoidin Domain Receptor 1 (DDR1), as a Potential Biomarker for Serous Ovarian Cancer
por: Quan, Jinhua, et al.
Publicado: (2011) -
Periostin interaction with discoidin domain receptor-1 (DDR1) promotes cartilage degeneration
por: Han, Tianzhen, et al.
Publicado: (2020) -
Structure-Based
Design of Tetrahydroisoquinoline-7-carboxamides
as Selective Discoidin Domain Receptor 1 (DDR1) Inhibitors
por: Wang, Zhen, et al.
Publicado: (2016)